FDA Turns the Spotlight on Regulatory Science: What Medical Device Developers Need to Know August 14, 2026 By Jennifer D. Newberger —

https://www.thefdalawblog.com/2026/08/fda-turns-the-spotlight-on-regulatory-science-what-medical-device-developers-need-to-know/?utm_source=rss&utm_medium=rss&utm_campaign=fda-turns-the-spotlight-on-regulatory-science-what-medical-device-developers-need-to-know CDRH’s September 25 public meeting offers a front-row seat to the science shaping the future of medical device review. Last week, the FDA’s Center for Devices and Radiological Health (CDRH) announced a public meeting titled “Regulatory Science Innovations Catalyzing Medical Device Development,” scheduled for September 25, 2026. For companies developing, manufacturing, or investing in medical devices, this event offers a rare opportunity to hear directly from the agency about the scientific tools and evidence standards that increasingly shape product review and approval decisions.